These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 31037714)

  • 1. Effect of Neoadjuvant Chemotherapy in Patients with Colorectal Cancer Liver Metastases.
    Sui K; Okabayashi T; Iwata J; Morita SM; Matsumoto T; Inada R; Iiyama T; Shimada Y; Kobayashi M
    Surg Technol Int; 2019 May; 34():208-214. PubMed ID: 31037714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical relevance of the Fong and the Nordlinger scores in the era of effective neoadjuvant chemotherapy for colorectal liver metastasis.
    Schreckenbach T; Malkomes P; Bechstein WO; Woeste G; Schnitzbauer AA; Ulrich F
    Surg Today; 2015 Dec; 45(12):1527-34. PubMed ID: 25563588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical risk scores in the current era of neoadjuvant chemotherapy for colorectal liver metastases.
    Kumar R; Dennison AR; Robertson V; Jones MJ; Neal CP; Garcea G
    ANZ J Surg; 2018 Jan; 88(1-2):E16-E20. PubMed ID: 27621179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognosis of liver resection for patients with four or more colorectal liver metastases has not improved in the era of modern chemotherapy.
    Hokuto D; Nomi T; Yamato I; Yasuda S; Obara S; Yoshikawa T; Kawaguchi C; Yamada T; Kanehiro H; Nakajima Y
    J Surg Oncol; 2016 Dec; 114(8):959-965. PubMed ID: 27683191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is neoadjuvant chemotherapy appropriate for patients with resectable liver metastases from colorectal cancer?
    Hirokawa F; Asakuma M; Komeda K; Shimizu T; Inoue Y; Kagota S; Tomioka A; Uchiyama K
    Surg Today; 2019 Jan; 49(1):82-89. PubMed ID: 30255329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Unresectable Recurrence After Up-Front Surgery for Colorectal Liver Metastasis.
    Hokuto D; Nomi T; Yasuda S; Yoshikawa T; Ishioka K; Yamada T; Akahori T; Nakagawa K; Nagai M; Nakamura K; Obara S; Kanehiro H; Sho M
    World J Surg; 2018 Mar; 42(3):884-891. PubMed ID: 28879511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of the primary tumor’s nodal status after surgery for colorectal liver metastases in the era of effective systemic therapy.
    van der Stok EP; Grünhagen DJ; Alberda WJ; Reitsma M; Rothbarth J; Verhoef C
    Dig Surg; 2015; 32(3):208-16. PubMed ID: 25896431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative adjuvant chemotherapy is important for improving long-term survival in patients with colorectal cancer liver metastases undergoing simultaneous resection.
    Zhong W; Xu B; Lu Y; Chang J; Xu L; Zhao H; Che X
    J Gastroenterol Hepatol; 2024 May; 39(5):908-919. PubMed ID: 38323685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of upfront hepatectomy without neoadjuvant chemotherapy for resectable colorectal liver metastasis.
    Ono K; Abe T; Oshita A; Sumi Y; Yano T; Okuda H; Kurayoshi M; Kobayashi T; Ohdan H; Noriyuki T; Nakahara M
    World J Surg Oncol; 2021 Apr; 19(1):97. PubMed ID: 33820549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topics related to neoadjuvant chemotherapy for resectable liver metastases from colorectal cancer.
    Ke S; Zhan S; Zhu H; Yan D
    J BUON; 2018; 23(2):296-301. PubMed ID: 29745068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bevacizumab improves survival in patients with synchronous colorectal liver metastases provided the primary tumor is resected first.
    Lim C; Doussot A; Osseis M; Esposito F; Salloum C; Calderaro J; Tournigand C; Azoulay D
    Clin Transl Oncol; 2018 Oct; 20(10):1274-1279. PubMed ID: 29594943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomogram for prediction of prognosis in patients with initially unresectable colorectal liver metastases.
    Imai K; Allard MA; Castro Benitez C; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Bismuth H; Baba H; Adam R
    Br J Surg; 2016 Apr; 103(5):590-9. PubMed ID: 26780341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival and recurrence after neo-adjuvant chemotherapy and liver resection for colorectal metastases: a ten year study.
    Karanjia ND; Lordan JT; Fawcett WJ; Quiney N; Worthington TR
    Eur J Surg Oncol; 2009 Aug; 35(8):838-43. PubMed ID: 19010633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of microscopic incomplete resection (R1) of colorectal liver metastases in the era of neoadjuvant chemotherapy.
    Ayez N; Lalmahomed ZS; Eggermont AM; Ijzermans JN; de Jonge J; van Montfort K; Verhoef C
    Ann Surg Oncol; 2012 May; 19(5):1618-27. PubMed ID: 22006375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection.
    Leung U; Gönen M; Allen PJ; Kingham TP; DeMatteo RP; Jarnagin WR; D'Angelica MI
    Ann Surg; 2017 Jan; 265(1):158-165. PubMed ID: 28009741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative Chemotherapy and Resection Margin Status in Colorectal Liver Metastasis Patients: A Propensity Score-Matched Analysis.
    Solaini L; Gardini A; Passardi A; Mirarchi MT; D'Acapito F; La Barba G; Cucchi M; Casadei Gardini A; Frassineti GL; Cucchetti A; Ercolani G
    Am Surg; 2019 May; 85(5):488-493. PubMed ID: 31126361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preoperative chemotherapy in the surgical treatment of colorectal liver metastases].
    Dede K; Láng I; Pörneczi B; Mester G; Fekete A; Kőszegi G; Mersich T; Besznyák I; Bursics A
    Magy Seb; 2013 Dec; 66(6):325-30. PubMed ID: 24333977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of margin status in liver resections for colorectal metastases after bevacizumab.
    Sasaki K; Margonis GA; Andreatos N; Wilson A; Weiss M; Wolfgang C; Sergentanis TN; Polychronidis G; He J; Pawlik TM
    Br J Surg; 2017 Jun; 104(7):926-935. PubMed ID: 28266705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of neoadjuvant chemotherapy in patients with high-risk resectable colorectal liver metastases.
    Ninomiya M; Emi Y; Motomura T; Tomino T; Iguchi T; Kayashima H; Harada N; Uchiyama H; Nishizaki T; Higashi H; Kuwano H
    Int J Clin Oncol; 2021 Dec; 26(12):2255-2264. PubMed ID: 34519930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy.
    Sakamoto Y; Miyamoto Y; Beppu T; Nitta H; Imai K; Hayashi H; Baba Y; Yoshida N; Chikamoto A; Baba H
    Anticancer Res; 2015 Apr; 35(4):2359-68. PubMed ID: 25862901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.